Autologous peroneus longus tendon graft for superior fulcrum reconstruction: Maintained prospective 1-year outcomes at short-term final follow-up
PLOS One · 2025
DOI: 10.1371/journal.pone.0336413 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Kehao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Third Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Rotator Cuff Injuries, Tendons, Plastic Surgery Procedures. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Key Research and Development Plan.
Abstract (Originalsprache)
Background
Massive irreparable rotator cuff tears (MIRCTs) present challenges in terms of traditional treatments and can result in pain and functional impairment. Due to the limitations of traditional treatments for MIRCTs, alternative options such as superior fulcrum reconstruction (SFR) using the autologous peroneus longus tendon (PLT) have been explored. This study aims to evaluate the clinical and radiographic outcomes of SFR with autologous PLT grafts for the treatment of MIRCTs after a minimum follow-up period of 1 year.
Methods
This was a prospective cohort study. Thirty-six patients with MIRCTs who underwent arthroscopic SFR with PLT grafts were enrolled and prospectively followed for a minimum of 1 year. Clinical and radiographic evaluations were performed preoperatively and at 3, 6, and 12 months postoperatively. Follow-up evaluations included assessments using the American Shoulder and Elbow Surgeons (ASES) score, Subjective Shoulder Value (SSV), visual analog scale (VAS), Quick-Disabilities of the Arm, Shoulder, and Hand (DASH) score, and measurements of shoulder joint range of motion. Radiography and MRI were used to evaluate the acromiohumeral distance (AHD), Hamada grade, and graft integrity. Repeated measures ANOVA was used to analyze the within-group and between-group differences under different conditions, followed by Bonferroni post-hoc tests to compare outcomes in the postoperative alignment subgroups.
Results
At the 1-year assessment (n = 36), 34 patients (94.4%) healed well and 2 (5.6%) had MRI-confirmed graft failure. Significant improvements were observed in ASES, QuickDASH, SSV, VAS, forward flexion, external rotation, internal rotation, and AHD scores (all P < 0.05). The use of autologous PLT grafts in SFR resulted in favorable functional outcomes, with a high graft healing rate at the 1-year follow-up.
Conclusions
Significant improvements were observed in the ASES, QuickDASH, SSV, VAS scores, and shoulder joint range of motion, highlighting the effectiveness of this approach for patients with MIRCTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Third Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
- The Fifth Clinical Medical College of Anhui Medical University, Hefei, Anhui, China.
- Hefei City's First People's Hospital, Hefei, Anhui, China.
ORCID-Profile: Rende Ning
Förderung
- Anhui Provincial Key Research and Development Plan
Zitieren
APA
Wang, K., Peng, C., Kong, L., Ning, R., Zhu, Z., Wang, J., Chen, G., Fang, R., & Tu, B. (2025). Autologous peroneus longus tendon graft for superior fulcrum reconstruction: Maintained prospective 1-year outcomes at short-term final follow-up. PLOS One. https://doi.org/10.1371/journal.pone.0336413
Vancouver
Wang K, Peng C, Kong L, Ning R, Zhu Z, Wang J, et al. Autologous peroneus longus tendon graft for superior fulcrum reconstruction: Maintained prospective 1-year outcomes at short-term final follow-up. PLOS One. 2025. doi:10.1371/journal.pone.0336413
BibTeX
@article{Wang2025,
author = {Wang, Kehao and Peng, Cheng and Kong, Lingchao and Ning, Rende and Zhu, Zheng and Wang, Junke and Chen, Guang and Fang, Run and Tu, Bizhi},
title = {Autologous peroneus longus tendon graft for superior fulcrum reconstruction: Maintained prospective 1-year outcomes at short-term final follow-up},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336413}
}
EUVIMED